| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $23.49 ▼ -0.97% | Yesterday | $23.82 ▲ +0.41% | Tomorrow's Chemours Company (The) Common Stock (CC) setup is anchored to $23.72 and targets $23.49 (-0.97%). The near-term read is downside; watch $24.43 / $23.01 because daily realized volatility is about 5.01%. |
Tomorrow's Chemours Company (The) Common Stock (CC) setup is anchored to $23.72 and targets $23.49 (-0.97%). The near-term read is downside; watch $24.43 / $23.01 because daily realized volatility is about 5.01%. | ||||
| Week | $23.00 ▼ -3.02% | Last Week | $24.02 ▲ +1.27% | The 7-day Chemours Company (The) Common Stock model moves from $24.02 to $23.00 (-3.02%). It gives downside momentum context for this stock, so breaks around $24.43 / $23.01 matter more than a single tick. |
The 7-day Chemours Company (The) Common Stock model moves from $24.02 to $23.00 (-3.02%). It gives downside momentum context for this stock, so breaks around $24.43 / $23.01 matter more than a single tick. | ||||
| Month | $22.19 ▼ -6.44% | Last Month | $24.36 ▲ +2.71% | The 1-month Chemours Company (The) Common Stock target is $22.19 (-6.44%), compared with the live reference near $23.72. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Chemours Company (The) Common Stock target is $22.19 (-6.44%), compared with the live reference near $23.72. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $20.98 ▼ -11.57% | Last Year | $24.87 ▲ +4.86% | The 1-year Chemours Company (The) Common Stock scenario points to $20.98 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Chemours Company (The) Common Stock scenario points to $20.98 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.13 ▼ -23.57% | 5 Years Ago | $26.07 ▲ +9.90% | The 5-year Chemours Company (The) Common Stock view is $18.13 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Chemours Company (The) Common Stock view is $18.13 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $23.72 | Mid |
| Daily Change | +1.72% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 61% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $23.72 | Daily Change | +1.72% |
| Market Cap | $3.56B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.